Reach Us +1-218-451-2974


Point of View about Erythropoietin in Treatment of Central Nervous System Diseases | OMICS International | Abstract
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mini Review

Point of View about Erythropoietin in Treatment of Central Nervous System Diseases

Liu-Zhu Yang1, Rui-Long Li1, Bo Wu2,5, Jin Luo1, Zhong Chen2*, Xin-Ping Yan3and Wei Tan4

1Department of Orthopedics, Hezhou city pepole's hospital, Hezhou, Guangxi, China

2Department of Orthopedics, Southern Medical University, Zhujiang Hospital, Guangzhou, Guangdong, China

3Department of Orthopedics, The Chinese People's Liberation Army 175 Hospital, Zhangzhou, Fujian, China

4Department of Orthopedics, The Third Pepole's Hospital of Huizhou, Affiliated Huizhou Hospital of Guangzhou Medical University, Huizhou, Guangdong, China

5Department of Orthopedics, The First Pepole's Hospital of Jingzhou, Jingzhou, Hubei, China

*Corresponding Author:
Zhong Chen
Department of Orthopedics, Southern Medical University
Zhujiang Hospital, Guangzhou, Guangdong, China
Tel: +86- 15778448908
E-mail: [email protected]

Received date: March 27, 2017; Accepted date: April 12, 2017; Published date: April 19, 2017

Citation: Yang LZ, Li RL, Wu B, Luo J, Chen Z, et al. (2017) Point of View about Erythropoietin in Treatment of Central Nervous System Diseases. J Alzheimers Dis Parkinsonism 7:320. doi:10.4172/2161-0460.1000320

Copyright: © 2017 Yang LZ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Spinal Cord Injury (SCI) is a complex process which leads to destruction of neuronal tissue and also vascular structure. Recent many studies have shown erythropoietin (EPO) has neuro-protective effects in acute SCI animal models. Alzheimer’s disease (AD), Parkinson’s disease (PD) and SCI belong to central nervous system diseases, a few studies also indicated that EPO may be effective for AD and PD. In this a short review article, we provide a short overview of the animal and human studies on rhEPO in SCI, AD and PD. Further clinical studies should reveal whether derivatives and variants of EPO provide any benefits over the clinical application EPO to against SCI, AD and PD in the experimental studies.


Google scholar citation report
Citations : 2275

Journal of Alzheimers Disease & Parkinsonism received 2275 citations as per google scholar report

Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page